INSIGHTS ON QUALITY ASSURANCE

• CQA Assessment Of LNP-Encapsulated IVT mRNA

  Learn more about issued guidelines on Critical Quality Attributes for IVT mRNA vaccines and biotherapeutics to focus on drug substance and LNP-encapsulated drug product assessment using an analyzer system.

• Dalton Pharma Service's Integrated Single Site Model

  A fully integrated single‑site model unifies development, manufacturing, formulation, fill‑finish, and quality oversight to reduce handoff risk and speed progression from API to sterile drug product.

• The Future Of GxP Manufacturing With AI

  Discover how to digitize batch records in just 180 days with Christian Gay Porcel by leveraging AI for automated compliance and scalable validation.

• Identification Of Conjugation Sites In An Antibody Drug Conjugate

  A streamlined workflow enables confident mapping of lysine-linked conjugation sites in ADCs. See how integrated automation and high-resolution analysis simplify complex characterization challenges.

• Preparing For Future Changes To USP <87>: What Customers Should Know Today

  7/16/2026

  Upcoming updates to a key bioreactivity standard could impact qualification, supplier oversight, and testing. Learn how in vitro and risk-based approaches may shape future compliance.

• Optimizing Contamination Control: Strategy Planning And Execution

  7/25/2025

  In a highly regulated environment, maintaining facility compliance is paramount. See how a robust contamination control strategy ensures compliance, product quality, and operational efficiency.

• Maintain Control Of Pharmaceutical Water Systems

  4/10/2026

  Early TOC excursions often reveal hidden risks in water systems. Capturing samples at the moment of deviation helps teams confirm root causes faster, reduce uncertainty, and maintain control.

• Predicting Performance Of Lotions Through Rheological Characterization

  5/6/2026

  Rheological testing shows how small formulation differences influence spreading, flow, and feel during use. With minimal sample volumes, these methods connect lab measurements to real‑world performance.

• Overcoming Volume And Viscosity Barriers In Biologic Formulations

  7/2/2026

  Learn how advanced containment solutions support high-viscosity biologics, improve device compatibility, enhance injection performance, and address evolving drug delivery and patient care challenges.